Accès ouvert
2026
article
OpenAlex
Fereshteh Yousefirizi, Sara Harsini, Mobin Mohebi, Ian Alberts et autres
Abstract Purpose. Prostate-specific membrane antigen (PSMA) PET/CT is routinely used to restage prostate cancer (PCa) in patients with biochemical recurrence (BCR), yet negative scans may still harbor subclinical disease. This study investigated whether radiomics features extracted from recurrence-prone organs on negative [ …
us, fr, ca, ir
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Maziar Sabouri, Ghasem Hajianfar, Omid Gharibi, Alireza Rafiei Sardouei et autres
Introduction: Peptide Receptor Radionuclide Therapy (PRRT) with [177Lu]Lu-DOTA-TATE is effective in treating advanced Neuroendocrine Tumors (NETs), yet predicting individual response in this treatment remains a challenge due to inter-lesion heterogeneity. There is a lack of standardized, effective methods for using multi-lesion radiomics …
ca, ch, us
(code pays fourni par la source)
2025
article
OpenAlex
Alejandro López-Montes, Fereshteh Yousefirizi, Yizhou Chen, Yazdan Salimi et autres
ch, ca
(code pays fourni par la source)
2025
conference-paper
OpenAlex
M. Sabouri, Ghasem Hajianfar, Omid Gharibi, Alireza Rafiei Sardouei et autres
Peptide Receptor Radionuclide Therapy (PRRT) using [${ }^{177}$Lu]Lu-DOTA-TATE has significantly improved outcomes for patients with advanced neuroendocrine tumors (NETs), yet predicting therapeutic response remains challenging. This study investigates whether aggregating radiomic features of different lesions extracted from pre-treatment somatostatin receptor PET/CT scans …
ca, ch, us
(code pays fourni par la source)
2025
article
OpenAlex
Pedro L. Esquinas, Fereshteh Yousefirizi, Ian Alberts, Nicolas A. Karakatsanis et autres
ca, us
(code pays fourni par la source)
2025
article
OpenAlex
Faraz Farhadi, Shadi A. Esfahani, Fereshteh Yousefirizi, Monica Luo et autres
us, ca
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Alejandro López-Montes, Fereshteh Yousefirizi, Yizhou Chen, Yazdan Salimi et autres
KEY WORDS: Artificial Intelligence (AI), Theranostics, Dosimetry, Radiopharmaceutical Therapy (RPT), Patient-friendly dosimetry KEY POINTS - The rapid evolution of radiopharmaceutical therapy (RPT) highlights the growing need for personalized and patient-centered dosimetry. - Artificial Intelligence (AI) offers solutions to the key limitations in …
Accès ouvert
2025
preprint
OpenAlex
Pedro L. Esquinas, Fereshteh Yousefirizi, Ian L. Alberts, Nicolas A. Karakatsanis et autres
Long-axial field-of-view (LAFOV) PET/CT has the potential to redefine the role of molecular imaging in theranostics by making multiparametric whole-body (MPWB) imaging and predictive dosimetry more clinically feasible. Compared to conventional PET systems, LAFOV scanners provide dramatic gains in sensitivity and coverage, …
Accès ouvert
2025
article
OpenAlex
Fereshteh Yousefirizi, Ghasem Hajianfar, Maziar Sabouri, Caroline Holloway et autres
Background: Cervical cancer remains a major global health concern, with high recurrence rates in advanced stages. [18F]FDG PET/CT provides prognostic biomarkers such as SUV, MTV, and TLG, though these are not routinely integrated into clinical protocols. Radiomics offers quantitative analysis of tumor …
ca, ch, us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Fereshteh Yousefirizi, Movindu Dassanayake, Alejandro López, Andrew J. Reader et autres
gb, ch, ca
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Movindu Dassanayake, Alejandro López, Andrew J. Reader, Gary Cook et autres
gb, ch, ca
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Monica Luo, Fereshteh Yousefirizi, Pouria Rouzrokh, Weina Jin et autres
Artificial intelligence (AI) is being explored for a growing range of applications in radiology, including image reconstruction, image segmentation, synthetic image generation, disease classification, worklist triage, and examination scheduling. However, training accurate AI models typically requires substantial amounts of expert-labeled data, which …
ca, us, om
(code pays fourni par la source)